Bayer is the only global company simultaneously researching improvements in human, animal and plant health. Systematic and intensive collaboration among researchers beyond their original specialization is providing new impetus. From world-renowned pharmaceutical products to high-tech platforms, from innovative diagnostics technologies to veterinary medicines – Bayer lives an innovation culture across national borders and areas of research.
Transitioning of current prescription medicines to OTC status (Rx-to-OTC switches) forms an integral part of our innovation strategy designed to offer new self-care solutions to consumers. In 2016, we were able to realize 30 new consumer-validated concept.